Skip to content

Public FDA record

Z-0556-2022: The EnPlace is a single use trans-vaginal pelvic floor repair system which enables delivery of a tissue a

Recall record Z-0556-2022 for FEMSelect Ltd. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0556-2022
Company in FDA record
FEMSelect Ltd
FDA record creation date
Feb 2, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Certain lots may not have been packaged wth the Channel Tube Limiter.

Source facts

Action
On Monday, December 13, 2021, FEMSelect alerted the US distributor both by phone and with a letter sent by email. The formal Recall Notice was sent on December 14, 2021. The recalling firm is requesting the return of the devices.
Initiated
2021-12-13
Root cause
Process design
Distribution
US Nationwide distribution in the state of Georgia.
Recall number
Z-0556-2022
Recall status
Open, Classified
CDRH record ID
191247
FDA record created
2022-02-02
Recall event number
89309

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗